Results 31 to 40 of about 869 (178)

Mast cell activation syndrome. About a clinical case

Revista Alergia México, 2019
Background: Monoclonal mast cell activation syndrome is included in mast cell activation disorders in which, after a diagnostic process, it is not possible to meet the required criteria for a diagnosis of systemic mastocytosis.
Ricardo Cardona, Maria Angélica Muñoz-Ávila, Catalina Gómez-Henao, Susana Diez-Zuluaga, Kenny Mauricio Gálvez-Cárdenas   +4 more
doaj   +1 more source

Mast cell-related disorders presenting with Kounis syndrome [PDF]

, 2016
Letter to the Editor.-- et al.Peer ...
Escribano, Luis, García-Montero, Andrés, Gonzalez-de-Olano, David, Jara-Acevedo, Maria, Matito, Almudena, Morgado, J. M., Orfao, Alberto, Sánchez-Muñoz, Laura, Teodosio, Cristina, Álvarez-Twose, Iván   +9 more
core   +1 more source

Mastocitosis Cutánea y Urticaria Pigmentosa: Estudio de Casos y Actualización Terapéutica [PDF]

, 2023
Cutaneous mastocytosis is a rare disease with a good prognosis. It is characterized by the invasion of mast cells, in abnormal amount, in the skin.
Burgos Iturra , Guillermo
core   +2 more sources

Definitions, Criteria and Global Classification of Mast Cell Disorders with Special Reference to Mast Cell Activation Syndromes: A Consensus Proposal [PDF]

, 2011
Activation of tissue mast cells (MCs) and their abnormal growth and accumulation in various organs are typically found in primary MC disorders also referred to as mastocytosis.
Akin C, Akin C, Akin C, Alberto Orfao, Alvarez-Twose I, Arock M, Arredondo AR, Austen KF, Awad JA, Bodemer C, Boguslaw Nedoszytko, Bonadonna P, Butterfield JH, Castells MC, Cem Akin, Chin KW, Costa JJ, Daley T, Dean D. Metcalfe, Di Lorenzo G, Donker ML, Finkelman FD, Galli SJ, Garcia-Montero AC, Golden DB, González de Olano D, Hans-Peter Horny, Hogan AD, Horny HP, Johansson SG, Jordan JH, Joseph H. Butterfield, Karin Hartmann, Karl Sotlar, Knut Brockow, Lawrence B. Schwartz, Lieberman P, Luis Escribano, Maintz L, Mariana Castells, Massimo Triggiani, Melody C. Carter, Metcalfe DD, Metcalfe DD, Metcalfe DD, Michel Arock, Morel AM, Murphy S, Nedoszytko B, Peavy RD, Peter Valent, Philip Lieberman, Rivera J, Rudolf Valenta, Ruëff F, Samorapoompichit P, Sampson HA, Schwartz LB, Schwartz LB, Schwartz LB, Schwelberger HG, Serafin WE, Sonneck K, Sperr WR, Vadas P, Valent P, Valent P, Valent P, Valent P, Valent P, van der Donk EM, van Toorenenbergen AW, Webb LM, Wolfgang R. Sperr   +73 more
core   +1 more source

PB1958 SUDDEN ONSET HEARING AND VISUAL LOSS: AN UNUSUAL PRESENTATION OF CHRONIC PHASE CHRONIC MYELOID LEUKEMIA

HemaSphere, Volume 3, Issue S1, Page 889-890, June 2019., 2019
Background: Hearing loss and blindness are seldom encountered as primary manifestations in patients with chronic myeloid leukemia. Chronic myeloid leukemia (CML) commonly presents with weakness, dysphagia, abdominal distension and pain and rarely constitutional symptoms.
S., S. Tandon, R. Gupta, S. Nityanand
wiley   +1 more source

Mastocitosis sistémica: Revisión sistemática [PDF]

Anales de Medicina Interna, 2008
La mastocitosis es una enfermedad definida por un crecimiento anormal y por la acumulación de mastocitos. En la clasificación de consenso de la OMS del 2001, se distinguió entre procesos bien limitados a piel (mastocitosis cutánea) o bien acumulados a nivel de otros tejidos: médula ósea y/u otros órganos extracutáneos (mastocitosis sistémica) como ...
Molina-Garrido, M.J., Mora, A., Guillén-Ponce, C., Guirado-Risueño, M., Molina, M.J., Molina, M.A., Carrato, A.   +6 more
openaire   +3 more sources

PB1959 THE ROLE OF FLOW CYTOMETRY IN DIFFERENTIAL DIAGNOSIS OF CMML AND REACTIVE MONOCYTOSIS. THE LIPID SIGNAL PATHWAY CHARACTERISTICS IN CLONAL MONOCYTOSIS

HemaSphere, Volume 3, Issue S1, Page 890, June 2019., 2019
Background: Myelodysplastic syndrome (MDS) is a heterogeneous group of diseases characterized by ineffective erythropoiesis and dysplasia. MDS and its subtype CMML is highly associated with chronic inflammatory and autoimmune diseases; however the combination of MDS with other bone marrow neoplasms is not a common entity. Only few cases of MDS combined
A. Sevoyan, A. Sevoyan
wiley   +1 more source

Mastocitoma solitario. Comunicación de un caso

Revista Alergia México, 2023
Antecedentes: El mastocitoma solitario es una variante de mastocitosis cutánea de buen pronóstico, congénita, que aparece durante las primeras semanas de vida.
Camila Delgadillo Jordán
doaj   +1 more source

How patients remember when they were given the diagnosis. About fifteen testimonies related to rare diseases [PDF]

, 2014
Doctor-patient communication has led, in recent years, great interest among the health community. Communicating the diagnosis is one of the key moments for people suffering an illness.
Arcos Urrutia, Juan Manuel, Bañon Hernández, Antonio M., Requena Romero, Samantha   +2 more
core   +2 more sources

PB1960 CHRONIC MYELOID LEUKEMIA DEVELOPING AFTER SYSTEMIC MASTOCYTOSIS: FAST AND COMPLETE MOLECULAR RESPONSE INDUCED BY IMATINIB.

HemaSphere, Volume 3, Issue S1, Page 890-891, June 2019., 2019
Background: We present here the case of a 52 year old male patient who was diagnosed of D816 V + indolent systemic mastocytosis in 2006. The patient received only symptomatic treatment with fexofenadine, sodium cromoglycate, and ranitidine. In November 7th 2016, mild leukocytosis was detected in one of the screenings.
A. Savchuk, W. Cabrera, E. Sola, J. Cornago, J.F. Del Campo, P. López‐Pereira, A. Orfao, I. Álvarez‐Twose, J.L. Steegmann   +8 more
wiley   +1 more source